CYHS1401459 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2015-07-10 | 苏州二叶制药有限公司 | Suzhou Erye Pharmaceutical Co Ltd | Certificate Issued | 2021-04-01 | view |
CYHB2100218 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 辉瑞制药(无锡)有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | In Review | 2021-02-04 | view |
CYHB2100217 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 辉瑞制药(无锡)有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | In Review | 2021-02-04 | view |
CYHS1900247 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(4) | Generic Drug | 2019-04-11 | 南京正大天晴制药有限公司 | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2020-07-29 | view |
CYHS1900246 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(4) | Generic Drug | 2019-04-11 | 南京正大天晴制药有限公司 | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2020-07-29 | view |
CYHB2050287 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2020-05-23 | 瀚晖制药有限公司 | HAN HUI Pharmaceuticals Co Ltd | In Review | 2020-05-22 | view |
JYHZ1700348 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2017-11-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-10-11 | view |
JYHZ1700347 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2017-11-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-10-11 | view |
JYHB1400857 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2014-07-01 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-04 | view |
JYHB1400858 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2014-07-01 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-04 | view |
CYHS1200097 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2012-07-06 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2017-03-07 | view |
JYHB1600406 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2016-04-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-03-07 | view |
JYHB1600407 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2016-04-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-03-07 | view |
CYHS1200096 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2012-07-06 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2017-03-07 | view |
JXHS1100103 | 盐酸伊达比星 | idarubicin hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2011-10-13 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2017-03-03 | view |
JXHS1100050 | 盐酸伊达比星 | idarubicin hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2011-04-25 | Synbias Pharma LLC | Synbias Pharma LLC | Certificate Issued | 2016-09-27 | view |
JYHB1500951 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2015-07-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
JYHB1500950 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2015-07-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
JYHB1501259 | 盐酸伊达比星胶囊 | idarubicin hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2015-09-28 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
CYHS1401458 | 盐酸伊达比星 | idarubicin hydrochloride | Active ingredient | Chemical Drugs(6) | Generic Drug | 2015-07-10 | 苏州二叶制药有限公司 | Suzhou Erye Pharmaceutical Co Ltd | In Review | 2015-07-09 | view |